Posted Sep. 30, 2011 at 9:54 a.m.

Premium Lock Charlotte firm's drug to treat Parkinson's advances

Published: 2011-09-30 09:54:43
Updated: 2011-09-30 09:54:43

Chelsea Chelsea

Chelsea Therapeutics filed the new drug application for Northera on Wednesday. Chelsea already has orphan drug status on Northera, its lead drug candidate. In its NDA filing, the company also requested Northera receive priority review, which could lead to an FDA decision on the drug as soon as the first quarter of next year....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders